STRATEC’s Share

STRATEC Biomedical AG has been publicly listed since August 1998. A total of 100,000 shares were issued at that time at a price of DM 52.00 each (EUR 26.59) in order to finance the company’s ongoing growth. Having accounted for the split and the conversion from DM to EUR, this is now equivalent to an issue price of EUR 2.96 per share.

The STRATEC Group is a rapidly growing international group and has an international shareholder structure. STRATEC’s share (ISIN: DE0007289001) is admitted to regulated trading in Germany at the Frankfurt Stock Exchange and is included in the Xetra electronic trading system.

The following pages provide you with an impression of the substance underlying STRATEC’s share.